Literature DB >> 28052059

Cancer genomics: Spot the difference.

Noah D Peyser1, Jennifer R Grandis1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28052059     DOI： 10.1038/nature21112

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.

Authors:  Tatsuhiro Shibata; Akiko Kokubu; Shigeru Saito; Mako Narisawa-Saito; Hiroki Sasaki; Kazuhiko Aoyagi; Yuki Yoshimatsu; Yuji Tachimori; Ryoji Kushima; Tohru Kiyono; Masayuki Yamamoto
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

2.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

3.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

4.  Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.

Authors:  Wei Wang; Yasuhiko Nishioka; Shuji Ozaki; Ali Jalili; Vinod Kumar Verma; Masaki Hanibuchi; Shinji Abe; Kazuo Minakuchi; Toshio Matsumoto; Saburo Sone
Journal:  Lung Cancer       Date:  2008-06-03       Impact factor: 5.705

5.  Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.

Authors:  Shoichiro Mukai; Naohide Oue; Takashi Oshima; Risa Mukai; Yoshiko Tatsumoto; Naoya Sakamoto; Kazuhiro Sentani; Kazuaki Tanabe; Hiroyuki Egi; Takao Hinoi; Hideki Ohdan; Wataru Yasui
Journal:  Ann Surg Oncol       Date:  2016-02-01       Impact factor: 5.344

6.  The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells.

Authors:  M Staudinger; P Glorius; R Burger; C Kellner; K Klausz; A Günther; R Repp; W Klapper; M Gramatzki; M Peipp
Journal:  Blood Cancer J       Date:  2014-06-13       Impact factor: 9.812

7.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

8.  Integrated genomic characterization of oesophageal carcinoma.

Authors: 
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

9.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

10.  CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.

Authors:  Kosuke Hiramatsu; Satoshi Serada; Kouji Kobiyama; Satoshi Nakagawa; Akiko Morimoto; Shinya Matsuzaki; Yutaka Ueda; Minoru Fujimoto; Kiyoshi Yoshino; Ken J Ishii; Takayuki Enomoto; Tadashi Kimura; Tetsuji Naka
Journal:  Cancer Sci       Date:  2015-10       Impact factor: 6.716
  10 in total
  3 in total

1.  Correction.

Authors: 
Journal:  Nature       Date:  2017-02-01       Impact factor: 49.962

Review 2.  Metabolic reprogramming in clear cell renal cell carcinoma.

Authors:  Hiromi I Wettersten; Omran Abu Aboud; Primo N Lara; Robert H Weiss
Journal:  Nat Rev Nephrol       Date:  2017-05-08       Impact factor: 28.314

Review 3.  Metabolomics and Metabolic Reprogramming in Kidney Cancer.

Authors:  Robert H Weiss
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.